Concepedia

Author

Mark Cabatingan

New York University

Also Known As

M S Cabatingan, Mark Cabatingan, Mark S Cabatingan, Mark S. Cabatingan

14

Publications

317

Citations

7

H-Index

14

Concepts

All Affiliations

New York UniversityNYU Langone HealthRoche (Switzerland)Multiple Sclerosis Center Of Northeastern New YorkUniversity of Massachusetts Chan Medical School
MC

About

Mark Cabatingan is an author at New York University specializing in virology, medicine, and biotechnology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

131

2

Engineering

1

1

99

3

Cell Biology

1

1

32

4

Immunology

1

1

32

5

Microbiology

1

1

99

Mark Cabatingan

×

7

Publications

300

Citations

7

H-Index

YearCitations

Normal‐flow virus filtration: detection and assessment of the endpoint in bioprocessing

Glen Bolton, Mark Cabatingan, Mike Rubino,

Biotechnology and Applied Biochemistry

2005

99

Naive B Lymphocytes Undergo Homeostatic Proliferation in Response to B Cell Deficit

Mark Cabatingan, Madelyn R. Schmidt, Ranjan Sen,

The Journal of Immunology

2002

85

Induction of herpes simplex virus type 1 immediate-early gene expression by a cellular activity expressed in Vero and NB41A3 cells after growth arrest-release

W Ralph, Mark Cabatingan, Priscilla A. Schaffer

Journal of Virology

1994

32

Expression of a Human Coxsackie/Adenovirus Receptor Transgene Permits Adenovirus Infection of Primary Lymphocytes

Madelyn R. Schmidt, Brian Piekos, Mark Cabatingan,

The Journal of Immunology

2000

26

Cellular and Humoral Immunity to SARS‐CoV‐2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease‐Modifying Therapies: A Multi‐Ethnic Observational Study

Ilya Kister, Y. Patskovsky, Ryan Curtin,

Annals of Neurology

2022

26

Site-Directed Mutagenesis of Large DNA Palindromes: Construction and In Vitro Characterization of Herpes Simplex Virus Type 1 Mutants Containing Point Mutations That Eliminate the oriL or oriS Initiation Function

John W. Balliet, Jonathan C. Min, Mark Cabatingan,

Journal of Virology

2005

18

Hybrid and vaccine‐induced immunity against <scp>SAR‐CoV</scp> ‐2 in <scp>MS</scp> patients on different disease‐modifying therapies

Ilya Kister, Ryan Curtin, Jinglan Pei,

Annals of Clinical and Translational Neurology

2022

14

Page 1